Literature DB >> 2858889

Anatomy and physiology of a nociceptive modulatory system.

H L Fields, M M Heinricher.   

Abstract

Although efferent control of sensory transmission is a well-established concept, a specific network for nociceptive modulation has only recently been discovered. This network includes interconnected components at midbrain, medullary and spinal levels. At the midbrain level, electrical stimulation of the periaqueductal grey (p.a.g.) inhibits spinal neurons that respond to noxious stimuli as well as nociceptor-induced reflexes and escape behaviour in a variety of species. Midbrain stimulation also produces analgesia in patients with clinically significant pain. The rostral ventral medulla (r.v.m.) has similar behavioural and physiological effects and mediates midbrain antinociceptive actions at the level of the spinal cord. Endorphins are present at all levels of this nociceptive modulating network. Opiate microinjections at p.a.g., r.v.m. or spinal levels produce analgesia, presumably by mimicking the actions of the endorphins. The nociceptive modulatory system is diffusely organized, highly interconnected and appears to act as a unit whether activated by opiates or electrical stimulation. There are two classes of r.v.m. neurons the activity of which is correlated with the occurrence of reflexes induced by noxious stimulation. One class (the on-cell) accelerates, the other class (the off-cell) pauses just before tail flick. Both classes project to the spinal cord and are excited by electrical stimulation of the midbrain. However, when morphine is injected either systemically or into the p.a.g., the off-cell is excited and the on-cell stops firing. The off-cell is probably the r.v.m. output cell that inhibits nociceptive transmission at the level of the spinal cord. The function of the on-cell is not clear. The nociceptive modulatory system can be activated by a variety of stressful environmental factors, which are often, but not necessarily, noxious. The idea that the system acts as a simple negative feedback circuit is not consistent with its known properties.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858889     DOI: 10.1098/rstb.1985.0037

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  65 in total

1.  Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance.

Authors:  T W Vanderah; N M Suenaga; M H Ossipov; T P Malan; J Lai; F Porreca
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

2.  Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor.

Authors:  F Porreca; S E Burgess; L R Gardell; T W Vanderah; T P Malan; M H Ossipov; D A Lappi; J Lai
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

Review 3.  Diencephalic and brainstem mechanisms in migraine.

Authors:  Simon Akerman; Philip R Holland; Peter J Goadsby
Journal:  Nat Rev Neurosci       Date:  2011-09-20       Impact factor: 34.870

Review 4.  Importance of anti- and pro-nociceptive mechanisms in human disease.

Authors:  I Tracey; P Dunckley
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

Review 5.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

6.  Are opioid-sensitive neurons in the rostral ventromedial medulla inhibitory interneurons?

Authors:  D R Cleary; M J Neubert; M M Heinricher
Journal:  Neuroscience       Date:  2007-11-04       Impact factor: 3.590

7.  Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "triptan" receptors: implications in migraine.

Authors:  Simon Akerman; Philip R Holland; Michele P Lasalandra; Peter J Goadsby
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

Review 8.  Pain imaging in health and disease--how far have we come?

Authors:  Petra Schweinhardt; M Catherine Bushnell
Journal:  J Clin Invest       Date:  2010-11-01       Impact factor: 14.808

9.  Adaptations in responsiveness of brainstem pain-modulating neurons in acute compared with chronic inflammation.

Authors:  Daniel R Cleary; Mary M Heinricher
Journal:  Pain       Date:  2013-02-28       Impact factor: 6.961

Review 10.  Descending control of nociception: Specificity, recruitment and plasticity.

Authors:  M M Heinricher; I Tavares; J L Leith; B M Lumb
Journal:  Brain Res Rev       Date:  2008-12-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.